Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy

Journal of Controlled Release

Volumn 194, Issue , 2014, Pages 82-91

  Schleich, Nathalie ^a   Po, Chrystelle ^a   Jacobs, Damien ^a   Ucakar, Bernard ^a   Gallez, Bernard ^a   Danhier, Fabienne ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

MRI; Nanoparticle; Paclitaxel; SPIO; Theranostic; Tumor targeting

Indexed keywords

NANOPARTICLES;

MAGNETIC TARGETING; PACLITAXEL; SPIO; THERANOSTIC; TUMOR IMAGING; TUMOR TARGETING;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; NANOPARTICLE; PACLITAXEL; SUPERPARAMAGNETIC IRON OXIDE; VITRONECTIN RECEPTOR; ANTINEOPLASTIC AGENT; FERRIC ION; FERRIC OXIDE; LACTIC ACID; METAL NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TARGETING; ELECTRON SPIN RESONANCE; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SURVIVAL TIME; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; DRUG SCREENING; MAGNETISM; METABOLISM; NEOPLASMS; PARTICLE SIZE; PROCEDURES; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; LACTIC ACID; MAGNETIC RESONANCE IMAGING; MAGNETICS; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; NEOPLASMS; PACLITAXEL; PARTICLE SIZE; POLYGLYCOLIC ACID; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84907194784     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.07.059     Document Type: Article

References (73)

1. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Nanotheranostics and image-guided drug delivery: current concepts and future directions Mol. Pharm. 7 6 2010 1899 1912
2. N. Ahmed, H. Fessi, and A. Elaissari Theranostic applications of nanoparticles in cancer Drug Discov. Today 17 17-18 2012 928 934
3. J. Xie, S. Lee, and X. Chen Nanoparticle-based theranostic agents Adv. Drug Deliv. Rev. 62 11 2010 1064 1079
4. S.M. Janib, A.S. Moses, and J.A. MacKay Imaging and drug delivery using theranostic nanoparticles Adv. Drug Deliv. Rev. 62 11 2010 1052 1063
5. L.Y. Rizzo, B. Theek, G. Storm, F. Kiessling, and T. Lammers Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications Curr. Opin. Biotechnol. 24 6 2013 1159 1166
6. T. Lammers, L.Y. Rizzo, G. Storm, and F. Kiessling Personalized nanomedicine Clin. Cancer Res. 18 18 2012 4889 4894
7. F. Danhier, O. Feron, and V. Préat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2 2010 135 146
8. F. Danhier, A. Le Breton, and V. Préat RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis Mol. Pharm. 9 11 2012 2961 2973
9. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 1-2 2000 271 284
10. S. Taurin, H. Nehoff, and K. Greish Anticancer nanomedicine and tumor vascular permeability; where is the missing link? J. Control. Release 164 3 2012 265 275
11. F. Danhier, B. Vroman, N. Lecouturier, N. Crokart, V. Pourcelle, H. Freichels, C. Jérôme, J. Marchand-Brynaert, O. Feron, and V. Préat Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel J. Control. Release 140 2 2009 166 173
12. Y. Liu, Y. Yang, and C. Zhang A concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin alphavbeta3 with magnetic probes Int. J. Nanomedicine 8 2013 1083 1093
13. E. Garanger, D. Boturyn, J.L. Coll, M.C. Favrot, and P. Dumy Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands Org. Biomol. Chem. 4 10 2006 1958 1965
14. E.A. Murphy, B.K. Majeti, L.A. Barnes, M. Makale, S.M. Weis, K. Lutu-Fuga, W. Wrasidlo, and D.A. Cheresh Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis Proc. Natl. Acad. Sci. U. S. A. 105 27 2008 9343 9348
15. H.N. Son, J.O. Nam, S. Kim, and I.S. Kim Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind alphavbeta3 integrin, leading to anti-angiogenic and anti-tumor effects Biochim. Biophys. Acta 1833 10 2013 2378 2388
16. J.L. Arias, L.H. Reddy, M. Othman, B. Gillet, D. Desmaele, F. Zouhiri, F. Dosio, R. Gref, and P. Couvreur Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics ACS Nano 5 2 2011 1513 1521
17. A.J. Cole, V.C. Yang, and A.E. David Cancer theranostics: the rise of targeted magnetic nanoparticles Trends Biotechnol. 29 7 2011 323 332
18. F. Danhier, P. Danhier, N. Magotteaux, G. De Preter, B. Ucakar, O. Karroum, B. Jordan, B. Gallez, and V. Préat Electron paramagnetic resonance highlights that the oxygen effect contributes to the radiosensitizing effect of paclitaxel PLoS One 7 7 2012 e40772
19. K.A. Radermacher, N. Beghein, S. Boutry, S. Laurent, E.L. Vander, R.N. Muller, B.F. Jordan, and B. Gallez In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy Invest. Radiol. 44 7 2009 398 404
20. K.A. Radermacher, J. Magat, C. Bouzin, S. Laurent, T. Dresselaers, U. Himmelreich, S. Boutry, I. Mahieu, E.L. Vander, O. Feron, R.N. Muller, B.F. Jordan, and B. Gallez Multimodal assessment of early tumor response to chemotherapy: comparison between diffusion-weighted MRI, 1H-MR spectroscopy of choline and USPIO particles targeted at cell death NMR Biomed. 25 4 2012 514 522
21. N. Schleich, P. Sibret, P. Danhier, B. Ucakar, S. Laurent, R.N. Muller, C. Jérôme, B. Gallez, V. Préat, and F. Danhier Dual anticancer drug/superparamagnetic iron oxide-loaded PLGA-based nanoparticles for cancer therapy and magnetic resonance imaging Int. J. Pharm. 447 1-2 2013 94 101
22. M. Garinot, V. Fievez, V. Pourcelle, F. Stoffelbach, A. des Rieux, L. Plapied, I. Theate, H. Freichels, C. Jérôme, J. Marchand-Brynaert, Y.J. Schneider, and V. Préat PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination J. Control. Release 120 3 2007 195 204
23. V. Pourcelle, H. Freichels, F. Stoffelbach, R. Auzely-Velty, C. Jérôme, and J. Marchand-Brynaert Light induced functionalization of PCL-PEG block copolymers for the covalent immobilization of biomolecules Biomacromolecules 10 4 2009 966 974
24. P. Danhier, G. De Preter, S. Boutry, I. Mahieu, P. Leveque, J. Magat, V. Haufroid, P. Sonveaux, C. Bouzin, O. Feron, R.N. Muller, B.F. Jordan, and B. Gallez Electron paramagnetic resonance as a sensitive tool to assess the iron oxide content in cells for MRI cell labeling studies Contrast Media Mol. Imaging 7 3 2012 302 307
25. F. Danhier, N. Lecouturier, B. Vroman, C. Jérôme, J. Marchand-Brynaert, O. Feron, and V. Préat Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation J. Control. Release 133 1 2009 11 17
26. H.W. Yang, M.Y. Hua, H.L. Liu, R.Y. Tsai, S.T. Pang, P.H. Hsu, H.J. Tang, T.C. Yen, and C.K. Chuang An epirubicin-conjugated nanocarrier with MRI function to overcome lethal multidrug-resistant bladder cancer Biomaterials 33 15 2012 3919 3930
27. J.A. Lyons, B.J. Sheahan, S.E. Galbraith, R. Mehra, G.J. Atkins, and M.N. Fleeton Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice Gene Ther. 14 6 2007 503 513
28. J.M. Oakes, E.C. Breen, M. Scadeng, G.S. Tchantchou, and C. Darquenne MRI-based measurements of aerosol deposition in the lung of healthy and elastase-treated rats J. Appl. Physiol. (1985) 116 12 2014 1561 1568
29. I.K. Kwon, S.C. Lee, B. Han, and K. Park Analysis on the current status of targeted drug delivery to tumors J. Control. Release 164 2 2012 108 114
30. K. Brindle New approaches for imaging tumour responses to treatment Nat. Rev. Cancer 8 2 2008 94 107
31. S. Laurent, and M. Mahmoudi Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer Int. J. Mol. Epidemiol. Genet. 2 4 2011 367 390
32. M. Hamoudeh, F.A. Al, E. Canet-Soulas, F. Bessueille, D. Leonard, and H. Fessi Elaboration of PLLA-based superparamagnetic nanoparticles: characterization, magnetic behaviour study and in vitro relaxivity evaluation Int. J. Pharm. 338 1-2 2007 248 257
33. Y. Ling, K. Wei, Y. Luo, X. Gao, and S. Zhong Dual docetaxel/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy Biomaterials 32 29 2011 7139 7150
34. J. Lu, S. Ma, J. Sun, C. Xia, C. Liu, Z. Wang, X. Zhao, F. Gao, Q. Gong, B. Song, X. Shuai, H. Ai, and Z. Gu Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging Biomaterials 30 15 2009 2919 2928
35. M. Talelli, C.J. Rijcken, T. Lammers, P.R. Seevinck, G. Storm, C.F. van Nostrum, and W.E. Hennink Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery Langmuir 25 4 2009 2060 2067
36. R.Y. Lin, K. Dayananda, T.J. Chen, C.Y. Chen, G.C. Liu, K.L. Lin, and Y.M. Wang Targeted RGD nanoparticles for highly sensitive in vivo integrin receptor imaging Contrast Media Mol. Imaging 7 1 2012 7 18
37. F. Zhang, X. Huang, L. Zhu, N. Guo, G. Niu, M. Swierczewska, S. Lee, H. Xu, A.Y. Wang, K.A. Mohamedali, M.G. Rosenblum, G. Lu, and X. Chen Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles Biomaterials 33 21 2012 5414 5422
38. A. Prokop, and J.M. Davidson Nanovehicular intracellular delivery systems J. Pharm. Sci. 97 9 2008 3518 3590
39. M. Wang, and M. Thanou Targeting nanoparticles to cancer Pharmacol. Res. 62 2 2010 90 99
40. M.P. Melancon, R.J. Stafford, and C. Li Challenges to effective cancer nanotheranostics J. Control. Release 164 2 2012 177 182
41. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 8 2010 615 627
42. P.E. Stromhaug, T.O. Berg, T. Gjoen, and P.O. Seglen Differences between fluid-phase endocytosis (pinocytosis) and receptor-mediated endocytosis in isolated rat hepatocytes Eur. J. Cell Biol. 73 1 1997 28 39
43. N. Bertrand, and J.C. Leroux The journey of a drug-carrier in the body: an anatomo-physiological perspective J. Control. Release 161 2 2012 152 163
44. J.E. Bae, M.I. Huh, B.K. Ryu, J.Y. Do, S.U. Jin, M.J. Moon, J.C. Jung, Y. Chang, E. Kim, S.G. Chi, G.H. Lee, and K.S. Chae The effect of static magnetic fields on the aggregation and cytotoxicity of magnetic nanoparticles Biomaterials 32 35 2011 9401 9414
45. W.J. Yang, J.H. Lee, S.C. Hong, J. Lee, J. Lee, and D.-W. Han Difference between Toxicities of Iron Oxide Magnetic Nanoparticles with Various Surface-Functional Groups against Human Normal Fibroblasts and Fibrosarcoma Cells Materials 6 2013 4689 4706
46. S. Laurent, A.A. Saei, S. Behzadi, A. Panahifar, and M. Mahmoudi Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges Expert Opin. Drug Deliv. 2014 1 22
47. T.K. Jain, M.K. Reddy, M.A. Morales, D.L. Leslie-Pelecky, and V. Labhasetwar Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats Mol. Pharm. 5 2 2008 316 327
48. L.H. Reddy, J.L. Arias, J. Nicolas, and P. Couvreur Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications Chem. Rev. 112 11 2012 5818 5878
49. A.S. Lubbe, C. Bergemann, W. Huhnt, T. Fricke, H. Riess, J.W. Brock, and D. Huhn Preclinical experiences with magnetic drug targeting: tolerance and efficacy Cancer Res. 56 20 1996 4694 4701
50. C. Alexiou, W. Arnold, R.J. Klein, F.G. Parak, P. Hulin, C. Bergemann, W. Erhardt, S. Wagenpfeil, and A.S. Lubbe Locoregional cancer treatment with magnetic drug targeting Cancer Res. 60 23 2000 6641 6648
51. B. Chertok, B.A. Moffat, A.E. David, F. Yu, C. Bergemann, B.D. Ross, and V.C. Yang Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors Biomaterials 29 4 2008 487 496
52. D.H. Kim, K.N. Kim, K.M. Kim, and Y.K. Lee Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia J. Biomed. Mater. Res. A 88 1 2009 1 11
53. A.S. Lubbe, C. Bergemann, H. Riess, F. Schriever, P. Reichardt, K. Possinger, M. Matthias, B. Dorken, F. Herrmann, R. Gurtler, P. Hohenberger, N. Haas, R. Sohr, B. Sander, A.J. Lemke, D. Ohlendorf, W. Huhnt, and D. Huhn Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors Cancer Res. 56 20 1996 4686 4693
54. M. Colombo, S. Carregal-Romero, M.F. Casula, L. Gutierrez, M.P. Morales, I.B. Bohm, J.T. Heverhagen, D. Prosperi, and W.J. Parak Biological applications of magnetic nanoparticles Chem. Soc. Rev. 41 11 2012 4306 4334
55. S. Larumbe, C. Gomez-Polo, J.I. Perez-Landazabal, and J.M. Pastor Effect of a SiO2 coating on the magnetic properties of Fe3O4 nanoparticles J. Phys. Condens. Matter 24 26 2012 266007
56. N. Shamim, L. Hong, K. Hidajat, and M.S. Uddin Thermosensitive polymer (N-isopropylacrylamide) coated nanomagnetic particles: preparation and characterization Colloids Surf. B: Biointerfaces 55 1 2007 51 58
57. A.G. Kolhatkar, A.C. Jamison, D. Litvinov, R.C. Willson, and T.R. Lee Tuning the magnetic properties of nanoparticles Int. J. Mol. Sci. 14 8 2013 15977 16009
58. P. Kocbek, S. Kralj, M.E. Kreft, and J. Kristl Targeting intracellular compartments by magnetic polymeric nanoparticles Eur. J. Pharm. Sci. 50 1 2013 130 138
59. A. Kumari, and S.K. Yadav Cellular interactions of therapeutically delivered nanoparticles Expert Opin. Drug Deliv. 8 2 2011 141 151
60. J. Folkman Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285 1971 1182 1186
61. R.K. Jain, D.G. Duda, J.W. Clark, and J.S. Loeffler Lessons from phase III clinical trials on anti-VEGF therapy for cancer Nat. Clin. Pract. Oncol 3 2006 24 40
62. C. Bouzin, and O. Feron Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery Drug Resist. Updat. 10 3 2007 109 120
63. R.K. Jain Transport of molecules in the tumor interstitium: a review Cancer Res. 47 12 1987 3039 3051
64. T.A. Bhat, and R.P. Singh Tumor angiogenesis - a potential target in cancer chemoprevention Food Chem. Toxicol. 46 4 2008 1334 1345
65. M.K. Gupta, and R.Y. Qin Mechanism and its regulation of tumor-induced angiogenesis World J. Gastroenterol. 9 6 2003 1144 1155
66. P. Danhier, G. De Preter, J. Magat, Q. Godechal, P.E. Porporato, B.F. Jordan, O. Feron, P. Sonveaux, and B. Gallez Multimodal cell tracking of a spontaneous metastasis model: comparison between MRI, electron paramagnetic resonance and bioluminescence Contrast Media Mol. Imaging 9 2 2014 143 153
67. M.H. Kranenborg, O.C. Boerman, J.C. Oosterwijk-Wakka, M.C. de Weijert, F.H. Corstens, and E. Oosterwijk Two-step radio-immunotargeting of renal-cell carcinoma xenografts in nude mice with anti-renal-cell-carcinoma X anti-DTPA bispecific monoclonal antibodies Int. J. Cancer 75 1 1998 74 80
68. K.T. Al-Jamal Active drug targeting: lessons learned and new things to consider Int. J. Pharm. 454 1 2013 525 526
69. J.H. Fang, Y.H. Lai, T.L. Chiu, Y.Y. Chen, S.H. Hu, and S.Y. Chen Magnetic core-shell nanocapsules with dual-targeting capabilities and co-delivery of multiple drugs to treat brain gliomas Adv. Healthc. Mater. 3 8 2014 1250 1260
70. Y. Yang, K. Yu, H. Zhang, J. Dai, and Z. Deng In vitro assessment of the dual-targeting behavior of a peptide-based magnetic resonance imaging contrast agent Int. J. Mol. Med. 33 1 2014 215 220
71. J.S. Desgrosellier, and D.A. Cheresh Integrins in cancer: biological implications and therapeutic opportunities Nat. Rev. Cancer 10 1 2010 9 22
72. E. Blanco, C.W. Kessinger, B.D. Sumer, and J. Gao Multifunctional micellar nanomedicine for cancer therapy Exp. Biol. Med. (Maywood) 234 2 2009 123 131
73. J.S. Guthi, S.G. Yang, G. Huang, S. Li, C. Khemtong, C.W. Kessinger, M. Peyton, J.D. Minna, K.C. Brown, and J. Gao MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells Mol. Pharm. 7 1 2010 32 40